2. US Food and Drug Administration. Instructions for Use (IFU): Pipeline Embolization Device, : Silver Spring, US Food and Drug Administration; 2011.
3. Patel PD, Chalouhi N, Atallah E, Tjoumakaris S, Hasan D, Zarzour H, et al. Off-label uses of the Pipeline embolization device: a review of the literature. Neurosurg Focus 2017;42:E4.
4. Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858-868.
6. Halbach VV, Higashida RT, Dowd CF, Urwin RW, Balousek PA, Lempert TE, et al. Cavernous internal carotid artery aneurysms treated with electrolytically detachable coils. J Neuroophthalmol 1997;17:231-239.
7. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke 2001;32:485-491.
8. Qureshi AI, Suarez JI, Parekh PD, Sung G, Geocadin R, Bhardwaj A, et al. Risk factors for multiple intracranial aneurysms. Neurosurgery 1998;43:22-26 ; discussion 26-27
9. Ellamushi HE, Grieve JP, Jäger HR, Kitchen ND. Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg 2001;94:728-732.
10. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000;49:147-152.
11. Arena JE, Hawkes MA, Farez MF, Pertierra L, Kohler AA, Marrodán M, et al. Headache and treatment of unruptured intracranial aneurysms. J Stroke Cerebrovasc Dis 2017;26:1098-1103.
13. Schneider AM, Moore JM, Adeeb N, Gupta R, Griessenauer CJ, Winkler PA, et al. Self-reported headaches in patients with unruptured intracranial aneurysms treated with the Pipeline embolization device. World Neurosurg 2018;113:e364-e372.
20. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg 2000;93:379-387.
24. Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442-447.
25. Chalouhi N, Zanaty M, Whiting A, Yang S, Tjoumakaris S, Hasan D, et al. Safety and efficacy of the Pipeline embolization device in 100 small intracranial aneurysms. J Neurosurg 2015;122:1498-1502.
27. Awad AW, Moon Moon, Yoon N, Mazur MD, Kalani MYS, Taussky P, et al. Flow diversion of tandem cerebral aneurysms: a multi-institutional retrospective study. Neurosurg Focus 2017;42:E10.
31. Ackroyd N, Gill R, Griffiths K, Kossoff G, Appleberg M. Quantitative common carotid artery blood flow: prediction of internal carotid artery stenosis. J Vasc Surg 1986;3:846-853.
33. Schneiders JJ, VanBavel E, Majoie CB, Ferns SP, van den Berg R. A flow-diverting stent is not a pressure-diverting stent. AJNR Am J Neuroradiol 2013;2013:E1-E4.
35. Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007;38:2346-2352.
36. Becske T, Brinjikji W, Potts MB, Kallmes DF, Shapiro M, Moran CJ, et al. Long-term clinical and angiographic outcomes following Pipeline embolization device treatment of complex internal carotid artery aneurysms: fiveyear results of the Pipeline for uncoilable or failed aneurysms trial. Neurosurgery 2017;80:40-48.
37. Imamura H, Sakai N, Sakai C, Fujinaka T, Ishii A, JR-NET Investigators. Endovascular treatment of aneurysmal subarachnoid hemorrhage in Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neurol Med Chir (Tokyo) 2014;54:81-90.